New York, NY, July 16, 2024 — A study recently published in Lupus Science and Medicine showed that krill oil concentrate helped to increase Omega-3 deficiency in people living with lupus. Secondary findings on a small subset of people with more severe lupus in the ORKIDS study suggest that krill oil concentrate may impact disease activity, but further study is warranted.
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, through the Lupus Clinical Investigators Network (LuCIN), supported Aker Biomarine and AMPEL Biosolutions, on the development and implementation of the ORKIDS study.
Research has shown that people with lupus are at an elevated risk of cardiovascular complications. Increasing Omega-3 Index to an optimal level through krill oil supplementation may show benefit for this population but warrants further study.
LRA President and CEO Albert T. Roy commented, “Initial data from the ORKIDS study has shed some light on the potential supportive option of Omega 3 for people with lupus. While not statistically significant, there were preliminary signals of improved disease activity in the small subset of patients with more severe lupus temporarily. These results will need to be confirmed with further study. Individuals with lupus should speak with their healthcare provider before making any changes to their treatment regimen.”
For more information about lupus, please see our educational resources.
